The National Academy of Medicine (NAM) today announced the Emerging Leaders in Health and Medicine. The individuals are early- to mid-career professionals from a wide range of health-related fields, such as basic and translational science, clinical medicine, bioengineering, federal health policy and law, and ethics. Young leaders in this program are selected by NAM leadership to engage in a variety of activities throughout the National Academies of Sciences, Engineering, and Medicine (National Academies) over a three-year term. Activities include biannual meetings in Washington, D.C., with NAM leadership; planning an annual Emerging Leaders Forum; participating in National Academies convening activities (such as standing committees, forums and roundtables, planning committees for workshops, and report review panels); publishing NAM Perspectives; and attending the NAM’s annual meeting each October.
“These exceptional individuals were selected to the National Academy of Medicine’s Emerging Leaders in Health and Medicine program for their leadership attributes and because they are poised to shape the future of health and medicine,” said NAM President Victor J. Dzau. “I look forward to engaging these impressive individuals, who are the next generation of scientists, health care providers, public health professionals, and policymakers, to develop a network of young leaders and catalyze innovative and cross-disciplinary activities addressing some of the most pressing challenges in health and medicine.”
The emerging leaders are:
- Paul Christopher, Ph.D., assistant professor of psychiatry and human behavior, Brown University
- Deidra C. Crews, M.D., Sc.M., associate professor of medicine, division of nephrology, and associate vice chair for diversity and inclusion, department of medicine, Johns Hopkins University School of Medicine
- Adaeze Enekwechi, Ph.D., vice president, McDermott+Consulting
- Lori Freedman, Ph.D., assistant professor, department of obstetrics, gynecology, and reproductive sciences, University of California, San Francisco
- Christopher Friese, Ph.D., R.N., AOCN, FAAN, Elizabeth Tone Hosmer Professor of Nursing, and director, Center for Improving Patient and Population Health, University of Michigan
- Jordan Green, Ph.D., professor of biomedical engineering, ophthalmology, oncology, neurosurgery, and materials science and engineering, Johns Hopkins University School of Medicine
- Marcia Haigis, Ph.D., associate professor, department of cell biology, Harvard University
- Sandeep Kishore, M.D., Ph.D., M.Sc., associate director, the Arnhold Institute for Global Health, Icahn School of Medicine, Mount Sinai Health
- Mark Neuman, M.D., assistant professor of anesthesiology and critical care, University of Pennsylvania
- Minal Patel, Ph.D., M.P.H., John G. Searle Assistant Professor, health behavior and health education, University of Michigan
- Suchi Saria, M.Sc., Ph.D., John C. Malone Assistant Professor, department of computer science, Johns Hopkins University
- Margaret (Gretchen) L. Schwarze, M.D., M.P.P., associate professor, division vascular of surgery, University of Wisconsin
- Julie Segre, Ph.D., chief and senior investigator, translational and functional genomics branch, National Human Genome Research Institute, National Institutes of Health
- Jacob Sherkow, J.D., professor of law, Innovation Center for Law and Technology, New York Law School
- Hanni Stoklosa, M.D., M.P.H., instructor in emergency medicine, Brigham and Women’s Hospital, Harvard Medical School
- Sohail Tavazoie, M.D., Ph.D., Leon Hess Associate Professor and head, Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology, The Rockefeller University
- Claire Wang, M.D., Sc.D., M.S., associate professor, health policy and management, Mailman School of Public Health, Columbia University
- Jonathan Watanabe, Pharm.D., M.S., Ph.D., BCGP, associate professor of clinical pharmacy, University of California, San Diego
- Joseph C. Wu, M.D., Ph.D., Simon H. Stertzer MD Professor of Medicine (Cardiology) and Radiology, and director, Stanford Cardiovascular Institute, Stanford School of Medicine
- Ramnik Xavier, M.D., Ch.B., chief of gastroenterology and director the Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital; Kurt Isselbacher Professor of Medicine, Harvard Medical School; and member, Broad Institute
The Emerging Leaders program facilitates opportunities for mentorship, collaboration, and innovation among the participants, NAM members, and experts across sectors. Emerging leaders provide valuable input and feedback to help shape the priorities of the NAM and sustain its impact and reputation as a national leader in advancing knowledge and accelerating progress in science, medicine, policy, and health equity.
Inaugural Emerging Leaders Forum
The emerging leaders are planning the inaugural NAM Emerging Leaders Forum, to be held in Washington, D.C., April 11-12, 2019. The forum will provide an opportunity for invited participants to share their activities and insights on cutting-edge developments in a wide range of fields through collaborative work and interdisciplinary discussions among the nation’s evolving leadership in health and medicine.
The National Academy of Medicine, established in 1970 as the Institute of Medicine, is an independent organization of eminent professionals from diverse fields including health and medicine; the natural, social, and behavioral sciences; and beyond. It serves alongside the National Academy of Sciences and the National Academy of Engineering as an adviser to the nation and the international community. Through its domestic and global initiatives, the NAM works to address critical issues in health, medicine, and related policy and inspire positive action across sectors. The NAM collaborates closely with its peer academies and other divisions within the National Academies of Sciences, Engineering, and Medicine.
Dana Korsen, Media Relations Officer
Andrew Robinson, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail email@example.com